Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis

被引:7
作者
Asesio, Nicolas [1 ]
Pollo-Flores, Priscila [1 ,2 ]
Caliez, Olivier [1 ]
Munteanu, Mona [3 ]
Ngo, An [3 ]
Ngo, Yen [3 ]
Poynard, Thierry [1 ,3 ,4 ]
Thabut, Dominique [1 ,4 ]
Rudler, Marika [1 ,4 ]
机构
[1] Hop La Pitie Salpetriere, Hepatol Dept, 47-83 Blvd Hop, F-75013 Paris, France
[2] Fluminenses Fed Univ UFF, CAPES coordenacao aperfeicoamento pessoal nivel Su, Rio De Janeiro, Brazil
[3] BioPredictive, Paris, France
[4] Sorbonne Univ, Inst Cardiometab & Nutr ICAN, Ctr Rech St Antoine CRSA, INSERM, Paris, France
关键词
Compensated advanced chronic liver disease; Portal hypertension; Hepatocellular carcinoma; SIGNIFICANT PORTAL-HYPERTENSION; CONSENSUS WORKSHOP; ESOPHAGEAL-VARICES; RISK; DIAGNOSIS; SURVIVAL; ELASTOGRAPHY; METHODOLOGY; VALIDATION; INDICATORS;
D O I
10.1016/j.dld.2021.09.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Combination of liver stiffness measurement and platelets count is a tool to safely rule out varices needing treatment (VNT) in patients with compensated advanced chronic liver disease (cACLD). Aims: to evaluate 4-year liver-related complications and survival in low-risk patients according to Baveno VI criteria. Methods: we conducted a monocentric retrospective analysis of prospectively collected data of all consecutive patients, with cirrhosis (LSM >= 12.5 kPa) and without previous complication, evaluated between 2012 and 2015. Liver-related complications and survival were compared between 2 groups of patients: favourable (LSM < 20 kPa and platelet count > 150.0 0 0/mm3) and unfavourable Baveno VI status patients (LSM >= 20 kPa or platelet count <= 150.0 0 0/mm3). Results: 455 patients with cACLD were analysed. Two hundred patients had favourable Baveno VI criteria, 3.6% with VNT. The 4-year probability of being free of acute decompensation was higher in low-risk patients (94.4 +/- 1.8% vs. 85.7% +/- 2.6%, p = 0.018). Unfavourable Baveno status was independently associated with acute decompensation. The probability of being free of HCC was significantly higher in low-risk patients (94.2 +/- 1.8% vs. 87.6 +/- 2.4%, p = 0.048). Liver-related mortality was not different between the 2 groups ( p = 0.56). Conclusion: The Baveno VI criteria could predict clinical outcome in cACLD. (c) 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:645 / 653
页数:9
相关论文
共 38 条
[1]   Noninvasive Tools and Risk of Clinically Significant Portal Hypertension and Varices in Compensated Cirrhosis: The "Anticipate" Study [J].
Abraldes, Juan G. ;
Bureau, Christophe ;
Stefanescu, Horia ;
Augustin, Salvador ;
Ney, Michael ;
Blasco, Helene ;
Procopet, Bogdan ;
Bosch, Jaime ;
Genesca, Joan ;
Berzigotti, Annalisa .
HEPATOLOGY, 2016, 64 (06) :2173-2184
[2]   Expanding the Baveno VI Criteria for the Screening of Varices in Patients With CompensatedAdvancedChronicLiverDisease [J].
Augustin, Salvador ;
Pons, Monica ;
Maurice, James B. ;
Bureau, Christophe ;
Stefanescu, Horia ;
Ney, Michel ;
Blasco, Helene ;
Procopet, Bogdan ;
Tsochatzis, Emmanuel ;
Westbrook, Rachel H. ;
Bosch, Jaime ;
Berzigotti, Annalisa ;
Abraldes, Juan G. ;
Genesca, Joan .
HEPATOLOGY, 2017, 66 (06) :1980-1988
[3]   Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy [J].
Bae, Joohwan ;
Sinn, Dong Hyun ;
Kang, Wonseok ;
Gwak, Geum-Youn ;
Choi, Moon Seok ;
Paik, Yong-Han ;
Lee, Joon Hyeok ;
Koh, Kwang Cheol ;
Paik, Seung Woon .
LIVER INTERNATIONAL, 2018, 38 (08) :1442-1448
[4]   Advances and challenges in cirrhosis and portal hypertension [J].
Berzigotti, Annalisa .
BMC MEDICINE, 2017, 15
[5]   Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis [J].
Berzigotti, Annalisa ;
Seijo, Susana ;
Arena, Umberto ;
Abraldes, Juan G. ;
Vizzutti, Francesco ;
Garcia-Pagan, Juan Carlos ;
Pinzani, Massimo ;
Bosch, Jaime .
GASTROENTEROLOGY, 2013, 144 (01) :102-U206
[6]   Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease [J].
Bureau, C. ;
Metivier, S. ;
Peron, J. M. ;
Selves, J. ;
Robic, M. A. ;
Gourraud, P. A. ;
Rouquet, O. ;
Dupuis, E. ;
Alric, L. ;
Vinel, J. P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) :1261-1268
[7]   Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies [J].
D'Amico, G ;
Garcia-Tsao, G ;
Pagliaro, L .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :217-231
[8]   Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients [J].
D'Amico, G. ;
Pasta, L. ;
Morabito, A. ;
D'Amico, M. ;
Caltagirone, M. ;
Malizia, G. ;
Tine, F. ;
Giannuoli, G. ;
Traina, M. ;
Vizzini, G. ;
Politi, F. ;
Luca, A. ;
Virdone, R. ;
Licata, A. ;
Pagliaro, L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) :1180-1193
[9]  
de Franchis R, 2000, J HEPATOL, V33, P846
[10]   Ruling out esophageal varices in NAFLD cirrhosis: Can we do without endoscopy? [J].
de Franchis, Roberto ;
Krag, Aleksander .
JOURNAL OF HEPATOLOGY, 2018, 69 (04) :769-771